MS&L opens Quebec office and names SVP

Share this article:
Manning Selvage & Lee (MS&L) named Lise Huneault as senior vice president and deputy manager of the firm's new office in Quebec. Under the leadership of Gayla Brock-Woodland, managing director of MS&L's Toronto office, MS&L is establishing a start-up in Montreal.
Huneault was vice president at National PharmaCom, Montreal, working with a number of pharmaceutical companies.
"Growing partnerships with clients in Quebec gave us a natural opportunity to create a solid foundation for MS&L in this important market," said Brock-Woodland. "The Montreal office will enhance MS&L's ability to service a number of national accounts."
"MS&L's entry into the Quebec market comes at a time when companies are looking for new PR agency options," says Huneault. "We can be a springboard for Quebec companies looking for a PR partner to support their expansion in Canada and internationally."
MS&L's new Montreal office will be housed within Publicis Canada offices Montreal. The firm will provide healthcare, consumer and corporate communications counsel in both French and English. The office will also work in partnership with sister agencies within the Publicis Groupe family.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.